FIGHT KIDS CANCER 2025-2026 Call for proposals

Der nachfolgende Text spiegelt nicht den gesamten Inhalt der Bekanntmachung wider, sondern enthält einzelne Auszüge der Richtlinie.

Die nachfolgenden Informationen sind nur auf Englisch verfügbar.

FIGHT KIDS CANCER is thrilled to announce that its next call opening on September 1st, will be dedicated to clinical and translational research in paediatric sarcoma.

Sarcomas are among the leading causes of cancer-related death in children—typically ranking second or third. Despite this burden, treatments for most sarcomas have seen little to no significant improvement over the past 40 years. To address these urgent unmet needs, the FIGHT KIDS CANCER Programme Committee has dedicated the 2025–2026 Call exclusively to paediatric bone or soft tissue sarcomas.

Paediatric cancers and their treatments differ from adult cancers. Hence, there is an urgent need for research projects developed specifically for children with cancer. FIGHT KIDS CANCER aims to catalyse and support pan-European leading-edge research initiatives in paediatric cancer to develop innovative approaches to improve the outcome for all children and adolescents with cancer.

This call will cover the following non-exclusive objectives:

• Realise real impact on young patients, 
• Improve survival rates and reduce toxicity to restore young patients to full health after treatment,
• Advance fundamental knowledge of paediatric malignancies,
• Support improved interdisciplinary research, methods and collaborations for tackling the issues of today,
• Strengthen collaboration and the development of scientific capacity across Europe.

FIGHT KIDS CANCER aims towards overcoming the structural lack of research dedicated to paediatric cancers by ensuring a recurring endowment that will be granted to the best European research projects every year. An additional ambition is to foster closer working ties between clinical and laboratory researchers.